Bacteria in the human gut play a significant role in the host's metabolic functions. These bacteria's metabolites have an impact on the host's physiology and health. The gut flora is subjected to a multitude of environmental factors, including way of life, strain, antibiotics, host genetics, and diseases. When a disease pathogenesis occurs, the intestinal microbial composition changes which results in a diseased state. This stage is caused by bacterial pathogen colonization in the intestinal environment. Probiotic strains can be injected into the intestinal environment to treat the pathological condition. Medicinal compounds produced by probiotic strains include amino acids, vitamins, bacteriocins, enzymes, immunomodulatory compounds, and Short-Chain Fatty Acids (SCFAs). This review describes latest proofs of the effect of bioactive components produced by probiotic bacteria on food and host wellbeing while having no impact on good bacteria sharing the same niche.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.